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Background: High frequency repetitive transcranial magnetic stimulation (rTMS) targetted to different cortical
regions (primary motor/sensory, prefrontal) are known to alter somatosensory responses. The mechanism(s) for
these effects are unclear. We compared the analgesic effects of rTMS at different cortical sites on hyperalgesia
induced using topical capsaicin cream.
Methods: Fourteen healthy subjects had capsaicin cream applied to a 16 cm2 area of the medial aspect of the
right wrist (60 min) on 4 separate occasions over 6 weeks. rTMS (10Hz for 10s/min = 2000 stimuli @ 90% resting
motor threshold of first dorsal interosseus muscle) was applied to the optimum site for right hand (M1), left
dorsolateral prefrontal (DLFPC) and occipital midline (OCC) in a pseudo-randomised order. Thermal and mechanical
perception and pain thresholds were determined using standardised quantitative sensory testing (QST) methods
at the capsaicin site. Subjective responses to thermal stimuli (pain score on a numerical rating scale) from −2.5°C
to +2.5°C of the individualised heat pain threshold (HPT) resulted in a hyperalgesia curve. Sensory testing took
place prior to capsaicin application (PRE-CAP), after 30 min of capsaicin (POST-CAP) and following rTMS
(30 min = POST-TMS).
Results: Capsaicin application resulted in substantial changes in thermal (but not mechanical) sensitivity to
both heat and cold (eg. HPT PRE-CAP = 43.6°C to POST-CAP = 36.7°C (p < 0.001)) with no differences between
groups pre-rTMS. POST-TMS HPT showed no changes for any of the treatment groups, however the pain scores
for the hyperalgesia curve were significantly lower for M1 vs OCC (−24.7%, p < 0.001) and for M1 vs DLFPC
(−18.3%, p < 0.02).
Conclusion: rTMS over the primary motor cortex results in a significant analgesic effect compared to other
cortical areas.
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Since the first report of the beneficial effects of epi-
dural motor cortex (M1) stimulation using implanted
electrodes in patients with chronic post-stroke pain [1]
many studies have confirmed the effectiveness of this
approach in a variety of pain conditions [2,3]. The limi-
tations and risk of complications of this approach have
led to the use of non-invasive brain stimulation to treat
patients with chronic pain, namely repetitive transcra-
nial magnetic stimulation (rTMS) [4,5] and transcranial
direct current stimulation (tDCS) [6]. The safety and
ease of use of these techniques has allowed investigation
of non-motor cortical areas such as pre-frontal cortex
[7,8], or somatosensory areas [9,10] with mixed success.
However, the optimal cortical targets for treating spe-
cific pain conditions as well as the potential mecha-
nisms by which pain relief occur are unclear.
Various types of experimentally induced pain have
been used to study the effects of non-invasive brain sti-
mulation on somatosensory responses in healthy sub-
jects. Summers et al. [11] found that rTMS over M1
reduced the temperature at which subjects reported a
thermode applied to the hand was perceived as painful,
but did not affect heat pain thresholds (suggesting an
effect on nociceptive A-delta but not C-fibres). In con-
trast, Graff-Guerrero et al. [12] found no change in re-
sponse to an arm cold pressor test following rTMS over
M1, but a significant increase in pain tolerance when
dorsolateral prefrontal cortex (DLPFC) was targetted.
Further evidence supporting the analgesic effects of
rTMS come from Nahmias et al. [13] who found that
both M1 and rTMS stimulation significantly increased
thermal pain thresholds in both hand and foot (al-
though these were more pronounced in the cold do-
main). Another model of experimental pain in which
rTMS has been used involves the use of the irritant
capsaicin, either injected intradermally, or topically
using a combination of heat and capsaicin to induce
a transient heat hyperalgesia [14,15]. Tamura et al.
[16] found that rTMS over M1 resulted in enhanced
recovery from pain induced by capsaicin injection
compared with sham rTMS or control. Brighina et al.
[17] compared rTMS of the left and right DLFPC on
pain responses to topical capsaicin application to both
hands and found significant bilateral pain reductions
after stimulating the left hemisphere only. It is not clear
whether the analgesic effect of stimulation of motor and
prefrontal cortices operate through similar pathways/
mechanisms.
Therefore this study aimed to directly compare the
efficacy of M1 vs left DFLPC stimulation in a topi-
cal capsaicin model of heat hyperalgesia, relative to a
control rTMS condition (stimulation of the occipital
fissure).Methods
Subjects
Fourteen healthy volunteers (eight female/six male, mean
age 23.6 years (18–51 year range)) gave informed written
consent to take part. Participants had no clinical symp-
toms or signs of peripheral or central nervous system dis-
orders and took no psychoactive medication. The study
was approved by Liverpool John Moores University Fac-
ulty of Science ethics committee and performed in accord-
ance with the declaration of Helsinki.
Thermal detection and pain thresholds
Both thermal detection and pain thresholds were measured
using Quantitative Sensory Testing (QST) via a MEDOC
TSA −2001 Thermal Sensory Analyzer (MEDOC, Israel).
The protocol for tests were based on the standardized
QST procedures developed by the German Network on
Neuropathic Pain [18]. A contact thermode which mea-
sured 25 mm × 25 mm was used to measure thermal re-
sponses at three sites: capsaicin site (CAPSITE) on the
medial aspect of the right wrist; the near capsaicin site
(nrCAPSITE) approximately 20 mm adjacent to the capsa-
icin site; and a contralateral capsaicin site (clCAPSITE) on
the medial aspect of the left wrist. The baseline tem-
perature of the contact thermode was 32°C (thermode
range 0°C – 50°C). Thermal detection and pain thresholds
were assessed at a constant room temperature of 22°C
using a method of limits paradigm. For cold detection
threshold (CDT) participants were instructed to click a
mouse button when they perceived the temperature of the
contact thermode decrease. Likewise for warmth detection
threshold (WDT) participants responded to a perceived
temperature increase. For cold/hot pain detection thresh-
olds (CPT/HPT) participants were instructed to click the
mouse button as soon as the temperature was perceived
“painful”. The rate of change was 1°C/2 s and each variable
was repeated three times. Thermal detection and pain
thresholds were taken as the mean score obtained.
Heat hyperalgesia curves
An 11-point Numerical Rating Scale (NRS) ranging from
0 (no pain) to 10 (worst pain imaginable) was used to as-
sess the pain perceived by participants. To obtain a heat
hyperalgesia curve19 subjects rated three different tem-
peratures derived from the hot pain threshold. These
consisted of three specific HPT, HPT + 2.5°C, and HPT-
2.5°C delivered three times in a random order to each
contact site. For each rating the chosen temperature was
maintained for two seconds before returning to baseline
(30°C) and the rate of change was 1°C/s.
Pressure pain thresholds
Pressure pain threshold (PPT) was measured using a
manual pressure algometer (Wagner Instruments, USA)
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placed perpendicular to the surface at each of the three
measurement sites and the pressure increased at a rate
of approximately 0.5 Kg/Sec. The patient was instructed
to indicate when the sensation of pressure first turned
into pain at which point the algometer would be re-
moved and the pressure reading taken. The average of
three measurements were made at each site.
Hyperalgesia
In order to sensitise the area of skin to facilitate the
capsaicin-induced hyperalgesia [14], the contact ther-
mode was applied to the CAPSITE and warmed to 41°C
for five minutes. Following this capsaicin cream (Axsain
0.075% w/w, Bioglan LTD, New Zealand) was applied
liberally to the area, ensuring a 1 cm overlap of the ther-
mode footprint. A transparent film dressing (6 cm ×
7cm Tegaderm™) was used to cover the capsaicin area
and the subject rested for 30 min.
Transcranial magnetic stimulation
TMS was delivered via a Nexstim NBS System (Nexstim,
Helsinki) using a focal figure-8 coil with 9 cm external
coil radius. Motor evoked potentials (MEPs) in response
to TMS were recorded from the first dorsal interosseus
muscle of the right hand using surface electromyography
(EMG) electrodes (Ambu Neuroline 720). EMG signals
were sampled at 3000 Hz and band-pass filtered between
10–500 Hz. In order to identify M1, motor thresholds
and stimulation parameters, single pulse TMS was deliv-
ered at 60% stimulator output at various scalp locations
over the inter-aural line of the left hemisphere of the
brain. The site over which the largest responses were ob-
tained (based on peak to peak MEP amplitudes) was
marked on the scalp and taken as the site for M1 stimu-
lation. Motor threshold was taken as the lowest stimulus
intensity at which MEPs of amplitude of >0.05 mV were
elicited in 5 out of 10 stimuli (mean threshold value =
37.8% (±3.6% s.e.m.). For rTMS, 100 stimuli were deliv-
ered over 10 s (10 Hz) each minute for 20 min (2000
stimuli) at 90% of the individual motor threshold level
for each session with the coil positioned to direct stimuli
anteriorly and perpendicular over the sulcus. For DLFPC
stimulation, the TMS coil was positioned 5 cm anterior
to M1 [19], and for occipital stimulation (OCC), over
the occipital tuberosity at the back of the head with
stimuli being directed anteriorly and parallel along the
interhemispheric fissue [20].
Psychological variables
Psychological factors including measures of emotion and
catastrophising have been shown to be related to pain
perception in clinical and experimental studies [21,22]
and thus may account for some of the variability in painreports. In the current study we used the Positive and
Negative Affect Schedule (PANAS) [23] to assess emo-
tion. The PANAS was designed to independently meas-
ure both positive affect (PA) and negative affect (NA)
states. It comprises 20 adjectives (10 for each scale, e.g.
Anger, Excited, Attentive) which participants are instruc-
ted to rate on a five-point scale from 1 ‘very slightly or
not at all’ to 5 ‘very much’ (1: very slight or not reflecting
the extent to which they currently felt the emotion. Total
scores for both PA and NA may range from 10–50. Partic-
ipants completed the PANAS at the start and end of each
session. Pain Catastrophising, generally conceptualized as
an exaggerated negative response to pain and its conse-
quences, includes the cognitive processes of magnification,
helplessness and rumination. We used the Pain Catastro-
phising Scale (PCS) [21] which asks participants to rate
the degree to which they experience the 13 statements
(e.g. I worry all the time whether the pain will end) when
in pain on a 5-point scale from 0 ‘not at al’) to 4 ‘all the
time’. Participants completed the PCS at the start of
each session.
Experimental design and protocol
A within-groups design was employed. There were two
independent variables which included the brain site for
rTMS, with four levels, no TMS, M1, DLPFC and OCC.
The second independent variable was time, with three
levels, PRE-CAP, POST-CAP (pre-TMS) and POST-TMS.
Dependent variables included the hot and cold sensory
and pain threshold temperatures, NRS scores obtained for
the heat hyperalgesia temperatures, pressure scores; posi-
tive affect, negative affect and pain catastrophising scores.
Each participant took part in four conditions, with
each visit at approximately the same time of day and a
seven day interval between each condition. Separate in-
vestigators carried out the sensory measures (M.P.) and
TMS (P.S.) in different laboratories The order of each
rTMS condition was randomised and coded (no TMS
was always the first) and only the investigator delivering
rTMS knew which stimulus location was used for each
session. Participants were instructed that on session two,
three and four they would have TMS at three different
brain sites. No more information was given about site
locations or the impact each site location may have on
subjective pain.
Each session followed the same protocol (with the
exception of the first, no TMS session). Subjects were
seated comfortably in an air-conditioned calm environ-
ment. The contact thermode was attached to CAPSITE
and the area was outlined with a non permanent marker
pen and QST and pressure pain measures were carried
out (PRE-CAP time point). This procedure was then re-
peated on the clCAPSITE and then the nrCAPSITE. The
contact thermode was then reapplied to the CAPSITE and
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ried out as described previously. After careful removal
of capsaicin the contact thermode was reapplied to the
CAPSITE and QST and pressure pain measures were re-
peated (POST-CAP time point). On completion capsaicin
cream was reapplied and covered for precisely 30 minutes.
For session one (no TMS) participants remained in the
sensory motor laboratory. On sessions two, three and four
participants went to the TMS laboratory for rTMS. Fol-
lowing rTMS participants returned and, after removal
of the capsaicin, sensory testing was repeated at the
CAPSITE, followed by the two non-capsaicin sites (POST-
TMS time point). Each session lasted approximately 3
hours and each stage in the protocol was carefully timed
for each subject to minimize variation between sessions.
Data analysis
All results are expressed as mean (±s.e.m. except where sta-
ted otherwise). Data were analysed using Excel (Microsoft,
USA) and SPSS (v20, IBM, USA). After confirming that
the data variables were normally distributed (Kolmogorov-
Smirnov test) within-within subjects repeated measures
ANOVA were used to assess the effect of rTMS and time
on the dependent variables at each time point for each
contact site. Where a significant rTMS/time interaction
was found post-hoc Bonferroni corrected paired t-tests
were conducted to further characterise any significant dif-
ferences between each of the rTMS sites. Repeated mea-
sures ANOVA was used to assess PANAS-PA at each time
point for each contact site. PANAS-NA was not normally
distributed, thus Kruskall-Wallis test was used to evaluate
differences across conditions at each time point. One way
ANOVA tested for differences in PCS score at baseline
and for each contact site.
Results
Topical capsaicin application was well tolerated by sub-
jects, although there was a progressive increase in sub-
jective pain over the course of 30 min (mean NRS at 5,Table 1 QST and heat hyperalgesia (HYP) responses
PRE-CAP POST-CAP
NO TMS OCC M1 DLFPC NO TMS OCC
CDT (°C) 30.2 (.25) 30.4 (.32) 29.5 (.57) 30.4 (.32) 28.4 (.58) 27.7
WDT (°C) 33.5 (.71) 34.1 (.34) 34.2 (.30) 33.5 (.12) 34.4 (.20) 35.0
CPT (°C) 17.4 (2.10) 13.0 (1.83) 13.0 (1.70) 15.6 (1.97) 8.3 (1.87) 12.1
HPT (°C) 42.9 (.96) 44.1 (.88) 44.4 (.88) 43.3 (.75) 36.8 (.71) 37.0
HYP- (NRS) 2.2 (.21) 1.1 (.12) 1.5 (.26) 1.2 (.18) 4.5 (.51) 2.7
HYP0 (NRS) 3.9 (.39) 2.7 (.36) 2.8 (.37) 2.5 (.34) 6.9 (.64) 5.3
HYP + (NRS) 6.0 (.50) 5.4 (.58) 5.2 (.44) 4.3 (.46) 8.6 (.57) 7.5
QST and heat hyperalgesia (HYP) responses for the capsaicin site at baseline, post-c
threshold; HST = heat sensory threshold; CPT = cold pain threshold; HPT = heat pain15 and 30 min were 0.3 (±0.2), 3.9 (±1.2) and 6.6 (±1.8)
respectively). QST values for the CAPSITE are shown
in Table 1. There was no significant effect of capsaicin
application on thermal sensory thresholds. In contrast
HPT temperature was dramatically reduced following cap-
saicin (Figure 1) by 6.4-7.2°C (range of means; p < 0.0001)
and this effect was reproducible over repeated sessions at
the same site one week apart (Figure 1), i.e. for each pro-
spective rTMS condition. There was also a trend for a re-
duction in CPT temperature at the CAPSITE (Table 1,
average mean changes 0.9-3.4°C, differences n.s.). Capsa-
icin application had no effect on QST responses at either
the nrCAPSITE or clCAPSITE (see Additional file 1:
Tables S1 and S2). Following the second capsaicin applica-
tion (with rTMS), there was a tendency for the HPT to be
further decreased, but no evidence for any effect of rTMS
(Figure 1). Similarly, rTMS had no effect on QST respon-
ses at either of the non-capsaicin sites (see Additional
file 1: Tables S1 and S2). The heat hyperalgesia curves
for the CAPSITE (Figure 2) demonstrated an approxi-
mate doubling in the NRS scores for the perceived pain
at the HPT following capsaicin application (from 2.67
(±0.35) to 5.63 ± 0.57), with similar responses for each
repeated measure (pre rTMS condition). This is despite
the fact that the HPT temperatures were substantially
lower following capasaicin application, demonstrating a
strong and reproducible hyperalgesic effect.
Following repeated capsaicin application (during which
rTMS was delivered) the heat hyperalgesia curves for the
three rTMS conditions showed a divergence (Figure 3).
There was a significant interaction between rTMS condi-
tion and time for the perceived pain ratings at HPT-2.5°C
(F(4,52) = 3.11, p < 0.001) and HPT (F(4,52) = 4.45, p < 0.001)
but not at HPT + 2.5°C (F(4,52) = 2.10, p = 0.139). NRS pain
reports were significantly lower for the M1 condition (des-
pite the fact that HPT temperatures were similar to the
two other rTMS conditions (Figure 1)). Subjects reported
consistently lower NRS scores following rTMS of the
DLFPC compared to OCC stimulation, but the differencesPOST-TMS
M1 DLFPC NO TMS OCC M1 DLFPC
(.82) 27.5 (.87) 27.1 (.78) 26.3 (.93) 28.0 (.61) 25.3 (1.14) 26.0 (.96)
(.46) 34.5 (.59) 35.0 (.21) 34.4 (.15) 34.5 (.49) 34.3 (.25) 34.3 (.20)
(2.20) 9.8 (1.84) 12.5 (1.75) 5.9 (1.85) 8.1 (2.35) 8.3 (1.75) 6.4 (1.54)
(.89) 37.0 (.86) 36.4 (.82) 36.1 (.89) 35.7 (.67) 36.0 (.65) 35.7 (.62)
(.50) 2.9 (.41) 2.8 (.40) 4.0 (.48) 3.5 (.45) 2.9 (.38) 2.1 (.34)
(.58) 5.7 (.50) 5.9 (.59) 7.8 (.36) 6.7 (.46) 6.1 (.54) 5.1 (.63)
(.51) 8.0 (.41) 7.9 (.58) 9.4 (.20) 8.7 (.29) 8.8 (.34) 7.9 (.57)
apsaicin and post combined capsaicin/rTMS treatment (CST = cold sensory
threshold; HYP- = HPT – 2.5°C; HYP0 = HPT; HYP + = HPT +2.5°C).
Figure 1 Heat Pain Thresholds (HPT) for skin sites pre- and
post-capsaicin and post-TMS. There was a highly significant
decrease following capsaicin application for all prospective TMS
sites. rTMS had no significant effect on HPT during the second
capsaicin application (OCC = occipital site; PFC = dorsolateral
prefrontal cortex site; M1 = primary motor cortex site).
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curves were observed at the non-capsaicin sites fol-
lowing rTMS.
Figure 4 shows the mean difference in NRS scores of
the POST-CAP vs POST-TMS heat hyperlagesia curves
for each rTMS condition. Following capsaicin applica-
tion with OCC stimulation, pain scores were signifi-
cantly higher than for the first capsaicin application
(mean increase = 1.37 (±0.31) at HPT (p < 0.001)). In con-
trast, when subjects received DLFPC stimulation there
was lesser or no change in pain scores for the equivalent
temperature (+0.42 (±0.38) at HPT, difference n.s.), with
smaller effects seen at the lower temperature levels. Most

























Figure 2 Heat hyperalgesia curves for the post-capsaicin phase. Capsa
at temperatures around the HPT (dashed line = average pre-capsaicin curvein a decrease in the pain provoked by temperatures
around the HPT (−0.84 (±0.53) at HPT, difference n.s.).
This equates to a −24.7% pain reduction compared to
OCC (p < 0.001) and a −18.3% reduction compared to the
DLPFC condition, and again this effect was more apparent
at lower temperatures (Figure 4).
There were no significant differences in positive affect
(PA) (F(3,52) = 1.94, ns) between the ‘no rTMS’ and three
rTMS conditions, or between the start and end of each
session (F(1,52) = 3.11, ns) (see Additional file 1: Table S3).
Similarly, non-parametric tests did not reveal any signi-
ficant differences in negative effect (NA) between ‘no
rTMS’ and three rTMS conditions, or from the start to
end of each session. In addition, scores on the PCS were
not significantly different between the no rTMS and three
rTMS conditions (see Additional file 1: Table S4). Partici-
pant scores on these measures were consistent with avail-
able normative data in healthy populations [21,23] for
PANAS and PCS respectively. However, given the relative
lack of variability in scores across conditions and time in
the current study, these data were not included in any fur-
ther analysis.
Discussion
This study found that the hyperalgesic effects of capsa-
icin application can be ameliorated by rTMS application
over the cortex, and this is most effective following sti-
mulation over the primary motor regions associated with
the affected area. Capsaicin is believed to cause hyper-
algesia via activation of nociceptive afferent C-fibres [24]
and this effect is enhanced when the skin is subjected to
a period of heat sensitization [14]. Unlike previous stud-
ies which have used topical capasacin alone to induce
hyperalgesia, our subjects reported significant pain during
application (although this resolved very quickly follo-






icin induced an approximate doubling of the perceived pain reported
). There were no differences between the prospective rTMS conditions.





























Figure 3 Heat hyperalgesia curves obtained following combined capsaicin/rTMS treatment. Subjects reported significantly reduced pain
scores following for the M1 condition compared to both non-motor rTMS sites (dashed line = average pre-capsaicin curve).
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tection, or pain pressure thresholds, but profoundly re-
duced heat pain threshold temperature (by some 7°C) and
to a lesser extent cold pain threshold (approx 2°C). This
effect was consistent and reproducible over several weekly
sessions, as demonstrated previously [15].
We compared responses to high frequency rTMS over
M1 and DLFPC sites to a “control” site over the occipital
fissure. We chose this site as most forms of sham TMS
are easily unblinded due to reduction in scalp sensations
associated with the sham coil. Occipital rTMS has beenFigure 4 Mean individual change in NRS of the heat
hyperalgesia test for post-capsaicin vs post-TMS conditions.
M1 scores were significantly lower than OCC for all temperatures
(*p < 0.03), and lower than PFC at the HPT (+p = 0.023). The PFC
condition was consistently lower than OCC and this was significant
at the HPT (#p = 0.033).used as a control in a number of previous studies [20,25]
and was well tolerated, with our participants reporting
similar sensations as for treatment over M1, with the only
difference being the occasional transient visual change
(usually expressed as a slight increase in perceived light
intensity). Therefore we believe that the OCC condition
was an appropriate control comparison for the active
rTMS sites.
We found that rTMS had no effect on any of the de-
tection or pain threshold values associated with capsa-
icin application, either at the site of capsaicin application
or on control sites. This somewhat contradicts previous
findings. Thus Nahmias et al. [13] and Grueff-Guerro
et al. [12] both found that rTMS over right hemisphere
DLPFC and M1 resulted in a reduction in cold pain thres-
hold temperature, whereas Borckhardt et al. [26] found
similar effects with left hemisphere DLFPC stimulation.
With regard to capsaicin-induced pain studies, rTMS
of contralateral M1 [16] and left DLPFC [27] were
found to reduce the pain associated with topical cap-
saicin application based on VAS scores. In this respect,
our findings are in accordance since we found that the
perceived pain associated with the HPT was significantly
lower following rTMS over M1 compared with the OCC
site. The subjective responses to heat pain were further re-
fined by using a heat hyperalgesia curve, with responses
obtained above and below HPT [28]. This confirmed the
clear analgesic effect of M1 stimulation, especially at
temperatures below HPT, and further demonstrated clear
differences between M1 and DLFPC. The convergence
of pain responses between rTMS conditions for the
HPT +2.5C measure presumably reflects a ceiling ef-
fect of the analgesic response.
A number of possible mechanisms for the analgesic ef-
fects of primary motor cortex rTMS have been proposed
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rect or indirect means [29]. These could include acti-
vation of corti-cortical pathways projecting to brain
areas associated with pain processing such as thala-
mus, anterior cingulate, insula, primary and secondary
somatosensory cortices, periaquaductal grey and rostral
ventromedullary areas [4,30–32]. Indeed, these areas
have been shown to be activated during heat induced
pain from capsaicin sensitive skin [33–36]. An indirect
regulation of the same region via the thalamus appears
equally possible. In particular TMS of M1 has been
shown to result in changes in activity of the ventrolat-
eral thalamus [30] and this area is believed to have a
role in sensory function [37]. In this context it is inter-
esting to note that Ohara et al. [38], using stereotactic
microstimulation of various thalamic regions in cons-
cious subjects, found that similar areas represented ther-
mal and pain sensations.
In central post stroke pain, the effect of TMS of M1 on
pain is critically dependent on the integrity of cortico-
thalamic and thalamo-cortical connections [39]. Recently,
indirect evidence has emerged that an additional mechan-
ism, modulation of the descending pathways, can also play
a role, as demonstrated for epidural motor cortex stimula-
tion induced analgesia [40]. Onesti et al. [41] showed that
during TMS of M1 for pain relief in diabetic neuropa-
thy the nociceptive R III reflex was reduced, and this is
thought to represent an inhibitory action from descending
neuromodulatory pathways. We found that M1 stimula-
tion had a significantly greater analgesic effect than that
of DLFPC, however the close association between pre-
frontal and motor areas is well recognized. With regard
to capsaicin-induced pain, Fierro et al. [27] found that
both MEP amplitude and intracortical inhibition of M1
were reduced, and that left DLPFC rTMS resulted in
both an analgesic effect and a normalisation of cortical
excitability measures, suggesting a causal association
between these phenomena. Moreover, Tamura et al. [16],
using positron emission tomography scanning, found
that the benefits of M1 rTMS from capsaicin-induced
pain were correlated with a decrease in regional cere-
bral blood flow to medial prefrontal areas and an in-
crease in blood flow to anterior cingulate. Regarding
the lack of a strong analgesic effect associated with
DLFPC stimulation, it must be acknowledged that a
limitation of this study is that we did not use MRI-
navigated TMS, and so can be less certain of the tar-
geting of our rTMS [19]. However, we believe that
this is unlikely to entirely explain the reduced effect-
iveness compared to M1 stimulation, since other studies
have used the same reference site for DLFPC targeting
[20]. Moreover, we did find a small but significant anal-
gesic effect of pre-frontal when compared to OCC stimu-
lation on pain responses at the HPT.Conclusion
In healthy subjects exposed to topical capsaicin-induced
hyperalgesia, rTMS over the primary motor cortex re-
sulted in a significant analgesic effect compared to other
cortical areas. There are clear limitations in extrapolat-
ing the findings of acute pain models to the use of rTMS
in the treatment of chronic pain syndromes since the
neural changes associated with the two types of pain
condition are likely to be different [42]. However our
findings of reduced heat hyperalgesia following capsaicin
application and rTMS of the primary motor cortex are
interesting in the context of Lefaucheur et al. [43] find-
ings that a similar pattern of stimulation in patients with
chronic neuropathic pain resulted in improvements in
both pain and warm sensory discrimination.
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